Bloks Group Limited — Interim / Quarterly Report 2003

Dec 27, 2002

Listed Company Information

HK PHARMA<00182> - Results Announcement Hong Kong Pharmaceutical Holdings Limited announced on 27/12/2002: (stock code: 00182 ) Year end date: 31/3/2003 Currency: HKD Auditors' Report: N/A Review of Interim Report by: Both Audit Committee and Auditors (Unaudited ) (Unaudited ) Last Current Corresponding Period Period from 1/4/2002 from 1/4/2001 to 30/9/2002 to 30/9/2001 Note ('000 ) ('000 ) Turnover : 49,806 27,379 Profit/(Loss) from Operations : (27,273) (17,918) Finance cost : (3,527) (3,064) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : N/A N/A Profit/(Loss) after Tax & MI : (23,193) (18,065) % Change over Last Period : N/A % EPS/(LPS)-Basic (in dollars) : (0.0168) (0.0132) -Diluted (in dollars) : N/A N/A Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : (23,193) (18,065) Interim Dividend : NIL NIL per Share (Specify if with other : N/A N/A options) B/C Dates for Interim Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: 1. LOSS PER SHARE The calculation of the basic loss per share is based on the net loss from ordinary activities attributable to shareholders for the period of approximately HK$23,193,000 (2001: HK$18,065,000) and on the weighted average of 1,383,629,485 (2001: 1,364,926,753) ordinary shares in issue during the period. Diluted loss per share for the six months ended 30 September 2002 and 2001 has not been presented as the effect of the assumed conversion of the share options and the convertible notes of the company during these periods was anti-dilutive. 2. DIVIDEND The Directors do not recommend the payment of any interim dividend for the six months ended 30 September 2002 (2001: Nil).